Zydus’ Amplitude receives CE mark for robotic surgical system ‘Andy’

Amplitude Surgical, a wholly owned subsidiary of Zydus MedTech France SAS, a wholly owned subsidiary of Ahmedabad-based Zydus Lifesciences, has announced that its proprietary robotic surgical system “Andy” has received CE mark approval.

This confirms its compliance with European standards for safety, performance, and quality and is a milestone in orthopaedic innovation. ‘Andy’ is built with its proprietary navigation platform, Amplivision. The CE-marked solution integrates Amplitude’s navigation technology with robotic assistance, developed through a strategic collaboration with eCential Robotics.

The Andy robotic surgical system marks a significant advancement in orthopaedic surgery. Conceived as a true surgical partner, Andy is a collaborative robot built on proprietary technology capable of performing bone resections with precision and reliability. This innovation empowers surgeons with greater confidence in the operating room and sets a new benchmark for robot-assisted procedures across Europe. 

Earlier this year, Zydus MedtTech expanded its global presence with the strategic acquisition of Amplitude Surgical a European MedTech company specializing in high-quality lower-limb orthopaedic technologies.